Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Minticid
- Development stage
- Unknown
- Lead developer
- Alico Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Minticid is an over-the-counter (OTC) antacid product developed by Alico Pharmaceutical. It is marketed as a dietary supplement or nutraceutical intended to provide relief from symptoms of gastric acidity, such as heartburn and acid indigestion. As an antacid, Minticid functions by neutralizing excess stomach acid (hydrochloric acid), thereby increasing gastric pH and alleviating the discomfort associated with acid reflux and dyspepsia. The product is part of Alico's consumer healthcare portfolio and is positioned for retail distribution as a consumer supplement rather than a clinical-stage pharmaceutical candidate.
- Brand names
- Minticid
- Other names
- Antacid Add
Beyond the preview
Go deeper on Minticid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Minticid.